2024 ICD-10-CM Diagnosis Code J84.10

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Atrophic fibrosis of lung
• Calcified granuloma of lung
• Chronic fibrosing pulmonary aspergillosis
• Chronic fibrosis of lung
• Chronic fibrosis of lung
• Chronic fibrosis of lung
• Chronic induration of lung
• Chronic interstitial pneumonia
• Chronic pulmonary aspergillosis
• Chronic pulmonary fibrosis caused by chemical vapors
• Chronic respiratory condition caused by vapors
• Confluent fibrosis of lung
• Congenital anomaly of endocrine ovary
• Diffuse interstitial pulmonary fibrosis
• Drug induced pulmonary fibrosis
• Drug-induced interstitial lung disorder
• Fibrosis of lung
• Hereditary fibrosing poikiloderma, tendon contractures, myopathy, pulmonary fibrosis syndrome
• Hereditary sclerosing poikiloderma
• Idiopathic pulmonary fibrosis
• Induration of lung
• Interstitial pulmonary fibrosis due to inhalation of drug
• Interstitial pulmonary fibrosis due to inhalation of substance
• Interstitial pulmonary fibrosis due to inhalation of substance
• Localized pulmonary fibrosis
• Lung fibrosis, immunodeficiency, 46,XX gonadal dysgenesis syndrome
• Massive fibrosis of lung
• Multiple hyalinizing granuloma of lung
• Multiple nodules of lung
• Nodular hyperplasia of liver
• Nodular regenerative hyperplasia of liver
• Nodule of liver
• Ovarian dysgenesis
• Perialveolar fibrosis of lung
• Peribronchial fibrosis of lung
• PF-ILD-progressive fibrosing interstitial lung disease
• Plasma cell granuloma of lung
• Post-inflammatory pulmonary fibrosis
• Pulmonary aspergillosis
• Pulmonary emphysema co-occurrent with fibrosis of lung
• Pulmonary fibrosis due to Hermansky-Pudlak syndrome
• Pulmonary fibrosis due to paracoccidioidomycosis
• Pulmonary fibrosis, hepatic hyperplasia, bone marrow hypoplasia syndrome
• Pulmonary granuloma
• Pulmonary hyalinizing granuloma
• Pulmonary hyalinizing granuloma
• Pulmonary nodular lymphoid hyperplasia
• Pure gonadal dysgenesis
• Pure gonadal dysgenesis 46,XX
• Respiratory condition caused by vapors
• Single hyalinizing granuloma of lung
• Solitary nodule of lung
• Tendon contracture

Clinical Information

• Asbestosis

  a form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. the disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium.

• Idiopathic Pulmonary Fibrosis

  a common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive dyspnea. pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.

• Pulmonary Fibrosis

  a process in which normal lung tissues are progressively replaced by fibroblasts and collagen causing an irreversible loss of the ability to transfer oxygen into the bloodstream via pulmonary alveoli. patients show progressive dyspnea finally resulting in death.

• Invasive Pulmonary Aspergillosis

  lung infections with the invasive forms of aspergillus, usually after surgery, transplantation, prolonged neutropenia or treatment with high-doses of corticosteroids. invasive pulmonary aspergillosis can progress to chronic necrotizing pulmonary aspergillosis or hematogenous spread to other organs.

• Pulmonary Aspergillosis

  infections of the respiratory tract with fungi of the genus aspergillus.

• Aspergillus

  a genus of mitosporic fungi containing about 100 species and eleven different teleomorphs in the family trichocomaceae.

• Dyspnea

  difficult or labored breathing.

• Localized Pulmonary Fibrosis

  replacement of the lung tissue by connective tissue in a specific area of the lung.

• Chronic Pulmonary Aspergillosis

  a spectrum of disorders associated with long-term aspergillus infection of the lung that usually occur in immunocompetent individuals with underlying respiratory disorders, and may be characterized by pulmonary fibrosis or cavitation.

J84.10 is grouped with Diagnostic Related Groups - MS-DRG Mapping

Diagnostic Related Groups (DRGs) are a classification system used to group together diagnosis codes for the purpose of reimbursement and healthcare management. DRGs are used to standardize the way hospitals and other providers are paid for inpatient services. In this system patients are grouped together based on their principal diagnosis in areas referred to as Major Diagnostic Categories (MDC). Once a patient is assigned a particular diagnostic category, providers receive a predetermined payment rate for the services rendered. This reimbursement rate is often fixed and is meant to cover the cost of care for that patient. Reimbursement is also affected by the relative weight of a diagnostic related group based on the severity of a patient's illness and the associated cost of care during hospitalization.

Diagnostic related groups encourage healthcare providers to focus on quality and efficiency in patient care while managing costs effectively. The diagnosis code is present in the following groups for version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

MS-DRG	MS-DRG Title	MCD	Relative Weight
196	INTERSTITIAL LUNG DISEASE WITH MCC	04	1.8954
197	INTERSTITIAL LUNG DISEASE WITH CC	04	0.9975
198	INTERSTITIAL LUNG DISEASE WITHOUT CC/MCC	04	0.7782

The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Convert J84.10 to ICD-9-CM

• ICD-9-CM Code: 515 - Postinflam pulm fibrosis
  Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education

Pulmonary Fibrosis

Pulmonary fibrosis is a condition in which the tissue deep in your lungs becomes scarred over time. This tissue gets thick and stiff. That makes it hard for you to catch your breath, and your blood may not get enough oxygen.

Causes of pulmonary fibrosis include environmental pollutants, some medicines, some connective tissue diseases, and interstitial lung disease. Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. In most cases, the cause cannot be found. This is called idiopathic pulmonary fibrosis.

Symptoms include:

• Shortness of breath
• A dry, hacking cough that doesn't get better
• Fatigue
• Weight loss for no known reason
• Aching muscles and joints
• Clubbing, which is the widening and rounding of the tips of the fingers or toes

Your doctor may use your medical history, imaging tests, a biopsy, and lung function tests to diagnose pulmonary fibrosis. There is no cure. Treatments can help with symptoms and improve your quality of life. They include medicines, oxygen therapy, pulmonary rehabilitation, or a lung transplant.

NIH: National Heart, Lung, and Blood Institute

[Learn More in MedlinePlus]

Idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis is a chronic, progressive lung disease. This condition causes scar tissue (fibrosis) to build up in the lungs, which makes the lungs unable to transport oxygen into the bloodstream effectively. The disease usually affects people between the ages of 50 and 70. Idiopathic pulmonary fibrosis belongs to a group of conditions called interstitial lung diseases (also known as ILD), which describes lung diseases that involve inflammation or scarring in the lung.

The most common signs and symptoms of idiopathic pulmonary fibrosis are shortness of breath and a persistent dry, hacking cough. Many affected individuals also experience a loss of appetite and gradual weight loss. Some people with idiopathic pulmonary fibrosis develop widened and rounded tips of the fingers and toes (clubbing) resulting from a shortage of oxygen. These features are relatively nonspecific; not everyone with these health problems has idiopathic pulmonary fibrosis. Other respiratory diseases, some of which are less serious, can cause similar signs and symptoms.

In people with idiopathic pulmonary fibrosis, scarring of the lungs increases over time until the lungs can no longer provide enough oxygen to the body's organs and tissues. Some people with idiopathic pulmonary fibrosis develop other serious lung conditions, including lung cancer, blood clots in the lungs (pulmonary emboli), pneumonia, or high blood pressure in the blood vessels that supply the lungs (pulmonary hypertension). Most affected individuals survive 3 to 5 years after their diagnosis. However, the course of the disease is highly variable; some affected people become seriously ill within a few months, while others may live with the disease for a decade or longer.

In most cases, idiopathic pulmonary fibrosis occurs in only one person in a family. These cases are described as sporadic. However, a small percentage of people with this disease have at least one other affected family member. When idiopathic pulmonary fibrosis occurs in multiple members of the same family, it is known as familial pulmonary fibrosis.

[Learn More in MedlinePlus]

Code History

• FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
• FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
• FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
• FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.